BIOMAT Database Logo BIOMAT Database Logo

[Clinico-immunological analysis of D-penicillamine use in rheumatoid arthritis]. 1980

E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001402 B-Lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. B-Cells, Lymphocyte,B-Lymphocyte,Bursa-Dependent Lymphocytes,B Cells, Lymphocyte,B Lymphocyte,B Lymphocytes,B-Cell, Lymphocyte,Bursa Dependent Lymphocytes,Bursa-Dependent Lymphocyte,Lymphocyte B-Cell,Lymphocyte B-Cells,Lymphocyte, Bursa-Dependent,Lymphocytes, Bursa-Dependent
D012217 Rheumatoid Factor Autoantibodies found in adult RHEUMATOID ARTHRITIS patients that are directed against GAMMA-CHAIN IMMUNOGLOBULINS. Factor, Rheumatoid
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
D-penicillamine in rheumatoid arthritis.
January 1986, Indian journal of pediatrics,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
[D-penicillamine in rheumatoid arthritis].
January 1979, Harefuah,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
[Clinico-immunological analysis of the use of antilymphocytic globulin in rheumatoid arthritis].
January 1980, Terapevticheskii arkhiv,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
Hepatotoxicity associated with use of D-penicillamine in rheumatoid arthritis.
April 1980, Annals of the rheumatic diseases,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
D-penicillamine withdrawal in rheumatoid arthritis.
April 1984, Annals of the rheumatic diseases,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
D-penicillamine in early rheumatoid arthritis.
January 1997, Clinical and experimental rheumatology,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
Editorial: D-penicillamine in rheumatoid arthritis.
May 1975, Lancet (London, England),
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
[Clinico-immunological comparisons in rheumatoid arthritis].
January 1988, Sovetskaia meditsina,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
Toxicity of D-penicillamine in rheumatoid arthritis.
January 1980, Annals of internal medicine,
E V Benenson, and R I Alibekova, and A Sh Seĭsenbaev, and L A Cherkasskiĭ, and R L Ivanova
[Clinico-immunological analysis of the use of nonsteroid anti-inflammatory agents in rheumatoid arthritis].
January 1984, Revmatologiia (Moscow, Russia),
Copied contents to your clipboard!